<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press Releases</title>
	<atom:link href="https://www.worldpharmatoday.com/press-releases/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Thu, 30 Apr 2026 09:45:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Press Releases</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal</title>
		<link>https://www.worldpharmatoday.com/press-releases/teva-adds-ecopipam-therapy-in-700m-emalex-acquisition-deal/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 30 Apr 2026 09:45:39 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Acquisition]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Treatments]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/teva-adds-ecopipam-therapy-in-700m-emalex-acquisition-deal/</guid>

					<description><![CDATA[<p>Teva Pharmaceuticals has entered into a definitive agreement to acquire Emalex Biosciences, strengthening its neuroscience pipeline through the addition of ecopipam, a late-stage investigational treatment for pediatric Tourette syndrome. The move reinforces the company’s strategic shift toward innovation-led expansion, with ecopipam positioned as a registration-ready, first-in-class selective dopamine D1 receptor antagonist. The asset has already [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/teva-adds-ecopipam-therapy-in-700m-emalex-acquisition-deal/">Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Husky and SEM Plastik Announce Strategic Collaboration to Advance Blood Collection Tube Manufacturing in Türkiye</title>
		<link>https://www.worldpharmatoday.com/press-releases/husky-and-sem-plastik-announce-strategic-collaboration-to-advance-blood-collection-tube-manufacturing-in-turkiye/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 28 Apr 2026 12:41:51 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/husky-and-sem-plastik-announce-strategic-collaboration-to-advance-blood-collection-tube-manufacturing-in-turkiye/</guid>

					<description><![CDATA[<p>Husky Technologies™, a global leader in precision injection molding solutions and services is collaborating with SEM Plastik San. ve Tic. A.Ş., under its SEM BIOTECH division, to support the company’s entry into blood collection tube manufacturing with the deployment of the ICHOR™ integrated medical system. The collaboration marks a significant milestone in SEM Plastik’s diversification [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/husky-and-sem-plastik-announce-strategic-collaboration-to-advance-blood-collection-tube-manufacturing-in-turkiye/">Husky and SEM Plastik Announce Strategic Collaboration to Advance Blood Collection Tube Manufacturing in Türkiye</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>BIO Asia &#8211; Taiwan 2026 to be Held in Mid-July in Taipei</title>
		<link>https://www.worldpharmatoday.com/press-releases/bio-asia-taiwan-2026-to-be-held-in-mid-july-in-taipei/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 22 Apr 2026 08:36:38 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/bio-asia-taiwan-2026-to-be-held-in-mid-july-in-taipei/</guid>

					<description><![CDATA[<p>Focusing on AI Integration to Unlock Opportunities for Accelerating Commercialization The annual event, BIO Asia &#8211; Taiwan 2026, jointly organized by Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO), will take place from July 15 to 19 at the Taipei Nangang Exhibition Center, TaiNEX 1 and 2. This year’s theme, [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/bio-asia-taiwan-2026-to-be-held-in-mid-july-in-taipei/">BIO Asia – Taiwan 2026 to be Held in Mid-July in Taipei</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>interpack 2026: &#8220;re:imagine Your Factory of the Future&#8221; – with Strategic Lifecycle Partner Syntegon</title>
		<link>https://www.worldpharmatoday.com/press-releases/interpack-2026-reimagine-your-factory-of-the-future-with-strategic-lifecycle-partner-syntegon/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 16 Apr 2026 08:45:37 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/interpack-2026-reimagine-your-factory-of-the-future-with-strategic-lifecycle-partner-syntegon/</guid>

					<description><![CDATA[<p>The “Factory of the Future” of pharma, biotech, and food companies must answer the most pressing industry challenges Automation, robotics, digitalization, and AI to enable human operators to focus on the highest value-adding tasks Syntegon’s contribution to “re:imagine” the Factory of the Future: neXt, SVX, SynTiso – backed by lifecycle services At interpack 2026, Syntegon [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/interpack-2026-reimagine-your-factory-of-the-future-with-strategic-lifecycle-partner-syntegon/">interpack 2026: “re:imagine Your Factory of the Future” – with Strategic Lifecycle Partner Syntegon</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>eschbach Unveils Shiftconnector Activity Scheduler</title>
		<link>https://www.worldpharmatoday.com/press-releases/eschbach-unveils-shiftconnector-activity-scheduler/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 02 Apr 2026 12:29:36 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/eschbach-unveils-shiftconnector-activity-scheduler/</guid>

					<description><![CDATA[<p>New feature helps pharma manufacturing teams streamline daily production planning, reduce manual work and improve on time batch execution. eschbach today announced the release of its new Shiftconnector Activity Scheduler, a feature designed to replace the spread sheet driven planning still common in pharmaceutical production environments with real time, equipment level scheduling and automated coordination. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/eschbach-unveils-shiftconnector-activity-scheduler/">eschbach Unveils Shiftconnector Activity Scheduler</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Kindeva® commemorates 70 years of pMDI Innovation</title>
		<link>https://www.worldpharmatoday.com/press-releases/kindeva-commemorates-70-years-of-pmdi-innovation/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 25 Mar 2026 13:33:05 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/kindeva-commemorates-70-years-of-pmdi-innovation/</guid>

					<description><![CDATA[<p>Kindeva® commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’ Kindeva, a global CDMO and drug delivery innovator, commemorates 70 years today, since the invention of the pressurized metered dose inhaler (pMDI), a breakthrough therapy that transformed respiratory care across the globe. Marking this momentous milestone, the [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/kindeva-commemorates-70-years-of-pmdi-innovation/">Kindeva® commemorates 70 years of pMDI Innovation</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase</title>
		<link>https://www.worldpharmatoday.com/press-releases/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 23 Mar 2026 13:33:19 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Acquisition]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/</guid>

					<description><![CDATA[<p>CVC reaffirms confidence in Syntegon&#8217;s strategic direction and continued growth potential Apollo acquires 37% minority stake and adds valuable expertise – particularly to further advance US expansion Continuation of Syntegon&#8217;s successful development: Since CVC&#8217;s investment, revenue has increased to a record EUR 1.75 billion operating profit has quadrupled Agreement provides the platform for accelerated growth [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/cvc-welcomes-apollo-as-minority-investor-in-syntegon-partnership-to-accelerate-next-growth-phase/">CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Syntegon and Lyocontract: Growing Together</title>
		<link>https://www.worldpharmatoday.com/press-releases/syntegon-and-lyocontract-growing-together/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 13 Mar 2026 11:12:12 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/syntegon-and-lyocontract-growing-together/</guid>

					<description><![CDATA[<p>Groundbreaking ceremony for 50-million-euro investment at LYOCONTRACT in Ilsenburg, Germany Complete vial line from Syntegon for freeze-dried pharmaceuticals Close partnership and seamless processes as the key to mutual success Demand for freeze-dried parenteral products in vials is increasing steadily. This also applies to contract manufacturer LYOCONTRACT, which has been producing in Ilsenburg, Germany, since 2012. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/syntegon-and-lyocontract-growing-together/">Syntegon and Lyocontract: Growing Together</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Kindeva Appoints Mike Cowhig as Chief Legal Officer</title>
		<link>https://www.worldpharmatoday.com/press-releases/kindeva-appoints-mike-cowhig-as-chief-legal-officer/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 11 Mar 2026 07:55:56 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/kindeva-appoints-mike-cowhig-as-chief-legal-officer/</guid>

					<description><![CDATA[<p>Kindeva, a global drug delivery contract development and manufacturing organization (CDMO), has today announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization. Bringing over 25 years of experience in the life sciences industry, Mike has previously held several Senior [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/kindeva-appoints-mike-cowhig-as-chief-legal-officer/">Kindeva Appoints Mike Cowhig as Chief Legal Officer</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Inizio Ignite Builds its Connected Solution with Key Leadership Appointments</title>
		<link>https://www.worldpharmatoday.com/press-releases/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 10 Mar 2026 11:31:07 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/</guid>

					<description><![CDATA[<p>Inizio Ignite, a fully integrated advisory partner, has today announced several key leadership appointments that support the activation and scale of its evolved, unified advisory solution. Designed to help health and life science companies shape strategy, drive transformation, and deliver measurable impact, Ignite’s leadership team will be central to delivering world-class support at every stage [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/inizio-ignite-builds-its-connected-solution-with-key-leadership-appointments/">Inizio Ignite Builds its Connected Solution with Key Leadership Appointments</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
